The European Journal of Internal Medicine recently published a study that should wake even the most steadfast deniers of the effectiveness of cannabis as medicine. The Israeli research team included the godfather of cannabis research, Raphael Mechoulam, the man who first identified cannabinoids (active compounds in the plant) and the system of receptors that make them effective.
The study was a large population analysis over a two-year period of nearly 3,000 patients, each with various types of cancer. Just over half of participants were in stage 4 of the disease when studied. About the same percentage said that the pain they had been experiencing was extreme. Their average age was 60.
Specific strains of cannabis from one producer were made available to patients. The specific reasons for use were primarily for pain, inducing sleep, nausea and lack of appetite.